Drug intelligence / Profile preview

Dormoysat

Development stage
Unknown
Lead developer
Hevert-Arzneimittel
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Dormoysat (specifically marketed as Dormoysat Schlaftropfen) is an over-the-counter homeopathic and herbal remedy developed and manufactured by Johannes Bürger YS Lab. It is formulated as oral drops containing a combination of three active herbal mother tinctures: Avena sativa (oat), Passiflora incarnata (passionflower), and Valeriana officinalis (valerian). Dormoysat is indicated for the treatment of nervous disorders and sleep disturbances, such as difficulty falling asleep and maintaining sleep. The combination of these natural ingredients works synergistically to promote relaxation, reduce nervous tension, and support healthy sleep patterns.

Brand names
DormoysatDormoysat Schlaftropfen
Other names
Avena sativa + Passiflora incarnata + Valeriana officinalisAvena sativa ø + Passiflora incarnata ø + Valeriana officinalis ø
02

Targets

ADOR (Adenosine receptors)GABRR (GABA-A receptor subunit rho)5-HT (Serotonin receptors)

Beyond the preview

Go deeper on Dormoysat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dormoysat.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call